Rutamarin
CAS: 13164-05-1
Ref. 3D-NAA16405
1mg | 436,00 € | ||
2mg | 621,00 € | ||
5mg | 1.044,00 € | ||
10mg | 1.739,00 € | ||
25mg | 3.913,00 € |
Información del producto
- (+)-Rutamarin
- (2S)-2-[1-(Acetyloxy)-1-methylethyl]-6-(1,1-dimethyl-2-propen-1-yl)-2,3-dihydro-7H-furo[3,2-g][1]benzopyran-7-one
- 7H-Furo[3,2-g][1]benzopyran-7-one, 2-[1-(acetyloxy)-1-methylethyl]-6-(1,1-dimethyl-2-propenyl)-2,3-dihydro-, (2S)-
- 7H-Furo[3,2-g][1]benzopyran-7-one, 6-(1,1-dimethylallyl)-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, acetate
- 7H-Furo[3,2-g][1]benzopyran-7-one, 6-(1,1-dimethylallyl)-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-,acetate (8CI)
- 7H-Furo[3,2-g][1]benzopyran-7-one,2-[1-(acetyloxy)-1-methylethyl]-6-(1,1-dimethyl-2-propenyl)-2,3-dihydro-, (2S)-(9CI)
- 7H-Furo[3,2-g][1]benzopyran-7-one,2-[1-(acetyloxy)-1-methylethyl]-6-(1,1-dimethyl-2-propenyl)-2,3-dihydro-, (S)-
- Chalepin acetate
- NSC 263654
- S-(+)-Chalepin acetate
- Ver más sinónimos
Rutamarin is a low molecular weight inhibitor with a molecular weight of 567. It binds to the ATP binding site of the mitochondrial membrane, thereby inhibiting its function. Rutamarin inhibits the production of inflammatory mediators in vitro and in vivo by inhibiting cyclooxygenase-2 (COX-2) and the COX-2-dependent synthesis of prostaglandins. Rutamarin also causes a reduction in colorectal adenocarcinoma cells, as well as metabolic profiles that are associated with carcinomas. This drug also affects fatty acid metabolism, which may be due to its inhibition of peroxisome proliferator activated receptor (PPAR).
Propiedades químicas
Consulta técnica sobre: 3D-NAA16405 Rutamarin
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.